๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Retinal Dystrophies

Development and Evaluation of Functional Visual Field and Navigation Endpoints in Moderate to Profound Inherited Retinal Disease (DEFINE-IRD) NCT07502664n/a1 site๐Ÿ“ Irvine Ray Therapeutics, Inc. Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site๐Ÿ“ Sioux Falls Sanford Health A Study About the Safety of a Single ASP2020 Eye Injection and if it Helps People With Vision Loss From Stargardt-type Eye Conditions NCT07734064Phase 14 sites๐Ÿ“ Phoenix๐Ÿ“ Southaven๐Ÿ“ Cincinnati Astellas Institute for Regenerative Medicine ยท Tests: ASP2020 Study of Subretinally Injected AAVB-081 in Patients With Usher Syndrome Type IB (USH1B) Retinitis Pigmentosa NCT06591793Phase 1, Phase 23 sites๐Ÿ“ Naples๐Ÿ“ London๐Ÿ“ London AAVantgarde Bio Srl ยท Tests: AAVB-081 Study of ALK-001 on the Progression of Stargardt Disease NCT07419334Phase 314 sites๐Ÿ“ Phoenix๐Ÿ“ Aurora๐Ÿ“ Gainesville Alkeus Pharmaceuticals, Inc. ยท Tests: ALK-001, Placebo A Study to Investigate the Safety of DSP-3077 After a Unilateral Eye Injection in Male and Female Participants 18 Years of Age or Older With Retinitis Pigmentosa NCT06891885Phase 1, Phase 22 sites๐Ÿ“ Boston๐Ÿ“ Minneapolis Sumitomo Pharma America, Inc. ยท Tests: DSP-3077 Retinal Sheet Cohort 1, DSP-3077 Retinal Sheet Cohort 2, DSP-3077 Retinal Sheet Cohort 3 Safety and Tolerability of Intravitreal Administration of VG901 in Patients With Retinitis Pigmentosa Due to Mutations in the CNGA1 Gene NCT06291935Phase 11 site๐Ÿ“ Tรผbingen VeonGen Therapeutics GmbH ยท Tests: VG901 Pilot Study of AuTNA I NCT05853107NA1 site๐Ÿ“ Shanghai Eye & ENT Hospital of Fudan University ยท Tests: AuTNA I Natural History Study of Advanced RCD NCT07854899NA3 sites๐Ÿ“ Ghent๐Ÿ“ Paris๐Ÿ“ Dublin SparingVision ยท Tests: Eye examinations, Questionnaire A Study to Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO) NCT06789445Phase 1, Phase 25 sites๐Ÿ“ Los Angeles๐Ÿ“ Miami๐Ÿ“ Philadelphia BlueRock Therapeutics ยท Tests: OpCT-001, OpCT-001 Adaptive Optics Imaging of Outer Retinal Diseases NCT05355415n/a2 sites๐Ÿ“ Bethesda๐Ÿ“ Silver Spring Food and Drug Administration (FDA) ยท Tests: Adaptive optics imaging Safety Evaluation Study of Pitavastatin PLGA Nano-particle for Retinitis Pigmentosa NCT07774975Phase 11 site๐Ÿ“ Fukuoka Kyushu University ยท Tests: ULREA-PVS-NP Brain Stimulation Effects on Orientation and Mobility Skills in Adults With Vision Impairment NCT07341763NA1 site๐Ÿ“ Waterloo University of Waterloo ยท Tests: Active hf-tRNS., Placebo/sham hf-tRNS Safety and Preliminary Efficacy of VG801 in Patients With ABCA4 Mutation-associated Retinal Dystrophy (Stargardt Disease) NCT07002398Phase 1, Phase 21 site๐Ÿ“ Shanghai VeonGen Therapeutics GmbH ยท Tests: VG801 Impact of Capsular Tension Ring on Intraocular Lens Position in Retinitis Pigmentosa Cataract Patients NCT07126470NA3 sites๐Ÿ“ Guangzhou๐Ÿ“ Shenzhen๐Ÿ“ Wuhan Zhongshan Ophthalmic Center, Sun Yat-sen University ยท Tests: CTR implantation BS01 in Patients With Retinitis Pigmentosa NCT04278131Phase 1, Phase 21 site๐Ÿ“ Teaneck Bionic Sight LLC ยท Tests: BS01 Familial Mediterranean Fever and Related Disorders: Genetics and Disease Characteristics NCT00001373n/a5 sites๐Ÿ“ Washington D.C.๐Ÿ“ Baltimore๐Ÿ“ Bethesda National Human Genome Research Institute (NHGRI) Virtual Reality Mobility Assessment of Functional Vision in Retinal Disease NCT04289571Phase 12 sites๐Ÿ“ Bethesda๐Ÿ“ Sydney National Eye Institute (NEI) ยท Tests: VR Mobility Tool Evaluation of Objective Perimetry Using Chromatic Multifocal Pupillometer NCT02014389n/a1 site๐Ÿ“ Tel HaShomer Sheba Medical Center A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults NCT07425574n/a15 sites๐Ÿ“ Phoenix๐Ÿ“ Palo Alto๐Ÿ“ Sacramento Astellas Pharma Global Development, Inc. ยท Tests: No Intervention National Ophthalmic Genotyping and Phenotyping Network (eyeGENE (Registered Trademark)), Stage 3 - Expansion of DNA and Data Repositories for Rare Inherited Ophthalmic Diseases NCT06491615n/a2 sites๐Ÿ“ Bethesda๐Ÿ“ Bethesda National Eye Institute (NEI) Safety and Efficacy Study of PUMCH-E111 Injection in Subjects With RLBP1 Related Inherited Retinal Dystrophy NCT07656753EARLY Phase 11 site๐Ÿ“ Beijing Peking Union Medical College Hospital ยท Tests: PUMCH-E111 Injection๏ผˆLow dose๏ผ‰, PUMCH-E111 Injection๏ผˆHigh dose๏ผ‰ A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1) NCT06942572Phase 1, Phase 25 sites๐Ÿ“ Aurora๐Ÿ“ Miami๐Ÿ“ Boston Splice Bio ยท Tests: SB-007 Observational Study to Investigate the Short-term Effects of Transcorneal Electrical Stimulation on Visual Performance NCT07548944n/a1 site๐Ÿ“ Frankfurt am Main Okuvision GmbH ยท Tests: Transcorneal Electrical Stimulation using the OkuStim System A 24-Month Trial of NPI-001 for the Preservation of Photoreceptors in Retinitis Pigmentosa Associated With Usher Syndrome NCT07710196Phase 31 site๐Ÿ“ Dallas Nacuity Pharmaceuticals, Inc. ยท Tests: Placebo, NPI-001 Safety and Efficacy of ZVS203e in the Treatment of Retinitis Pigmentosa Caused by RHO Gene Mutation NCT06952842Phase 1, Phase 21 site๐Ÿ“ Beijing Chigenovo Co., Ltd ยท Tests: ZVS203e Experimental and Clinical Studies of Retinal Stimulation NCT03635645NA1 site๐Ÿ“ Ann Arbor University of Michigan ยท Tests: New visual processing unit (VPU) with asymmetric waveforms, New VPU with bipolar stimulation North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC) NCT01694940n/a17 sites๐Ÿ“ San Diego๐Ÿ“ Stanford๐Ÿ“ Aurora Columbia University Study to Evaluate the Efficacy of a Single Intravitreal Injection of RTx-015 in Participants With Retinitis Pigmentosa (PERCEPT) NCT07901751Phase 2, Phase 314 sites๐Ÿ“ Phoenix๐Ÿ“ Bakersfield๐Ÿ“ Beverly Hills Ray Therapeutics, Inc. ยท Tests: RTx-015, Sham Control A Phase II Study of Intravitreal KIO-301 in Patients With Late-stage Retinitis Pigmentosa NCT06628947Phase 25 sites๐Ÿ“ Sydney๐Ÿ“ Woolloongabba๐Ÿ“ Adelaide Kiora Pharmaceuticals, Inc. ยท Tests: Placebo (Sterile Saline or Balanced Salt Solution), 100 ฮผg KIO-301, 50 ฮผg KIO-301
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy